Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2025-12-26 @ 1:08 AM
NCT ID: NCT00979134
Description: None
Frequency Threshold: 5
Time Frame: AEs were collected on a continual basis from Screening up until the end of the 28 day follow up period.
Study: NCT00979134
Study Brief: Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Part B Dose expansion phase (80mg bd tablet) None None 1 6 6 6 View
Part C (FISH Ratio >= 2) Dose expansion in patients with FGFR gene-amplified tumours None None 10 33 33 33 View
Part A Dose escalation None None 11 43 43 43 View
Part C (FISH Ratio < 2) Dose expansionj in patients with FGFR gene-amplified tumours None None 3 12 12 12 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Renal failure SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA Version 14.1. View
Anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA Version 14.1. View
ALT increased SYSTEMATIC_ASSESSMENT Investigations MedDRA Version 14.1. View
GGT increased SYSTEMATIC_ASSESSMENT Investigations MedDRA Version 14.1. View
Hydronephrosis SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA Version 14.1. View
Lung disorder SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA Version 14.1. View
Nephrolithiasis SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA Version 14.1. View
Pelvi-ureteric obstruction SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA Version 14.1. View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA Version 14.1. View
Retinal detachment SYSTEMATIC_ASSESSMENT Eye disorders MedDRA Version 14.1. View
Tumour associated fever SYSTEMATIC_ASSESSMENT General disorders MedDRA Version 14.1. View
Blood creatinine increased SYSTEMATIC_ASSESSMENT Investigations MedDRA Version 14.1. View
General physical health deterioration SYSTEMATIC_ASSESSMENT General disorders MedDRA Version 14.1. View
Asthenia SYSTEMATIC_ASSESSMENT General disorders MedDRA Version 14.1. View
Chorioretinopathy SYSTEMATIC_ASSESSMENT Eye disorders MedDRA Version 14.1. View
Dehydration SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA Version 14.1. View
Atrial flutter SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA Version 14.1. View
Bile duct obstruction SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA Version 14.1. View
Decreased appetite SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Version 14.1. View
Delirium SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA Version 14.1. View
Epilepsy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Version 14.1. View
Euthanasia SYSTEMATIC_ASSESSMENT Social circumstances MedDRA Version 14.1. View
Hyponatraemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA Version 14.1. View
Hypotension SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Version 14.1. View
Hypoxia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA Version 14.1. View
Pericardial effusion SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA Version 14.1. View
Pleural effusion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA Version 14.1. View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Version 14.1. View
Respiratory failure SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA Version 14.1. View
Sepsis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Version 14.1. View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Version 14.1. View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA Version 14.1. View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Version 14.1. View
Alopecia SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA Version 14.1. View
Dry mouth SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Version 14.1. View
Stomatis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Version 14.1. View
Hyperphosphataemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA Version 14.1. View
Dry skin SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA Version 14.1. View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Version 14.1. View
Nail disorder SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA Version 14.1. View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Version 14.1. View
Decreased appetite SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA Version 14.1. View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Version 14.1. View
Asthenia SYSTEMATIC_ASSESSMENT General disorders MedDRA Version 14.1. View
Dry eye SYSTEMATIC_ASSESSMENT Eye disorders MedDRA Version 14.1. View
Dyspnoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA Version 14.1. View
Epistaxis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA Version 14.1. View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Version 14.1. View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA Version 14.1. View
Abdominal pain SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Version 14.1. View
Dysgeusia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Version 14.1. View
Muscle spasms SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Version 14.1. View
Dysphonia SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA Version 14.1. View
Breath sounds abnormal SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA Version 14.1. View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA Version 14.1. View
Ageusia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA Version 14.1. View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA Version 14.1. View
Lethargy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Version 14.1. View
Oedema peripheral SYSTEMATIC_ASSESSMENT Eye disorders MedDRA Version 14.1. View
ALT increased SYSTEMATIC_ASSESSMENT Investigations MedDRA Version 14.1. View
Anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA Version 14.1. View
Insomnia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Version 14.1. View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA Version 14.1. View
Dyspepsia SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Version 14.1. View
Nasal congestion SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA Version 14.1. View
Dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA Version 14.1. View